Myelodysplastic Syndrome

Explore the newest developments in clinical research and treatment for myelodysplastic syndromes (MDS). Cancer Nursing Today has the latest clinical findings and perspectives on personalized risk prediction models for MDS, genetic mutations related to MDS progression, donor lymphocyte infusions, and more. From clinical trials and screening techniques to the latest treatments, learn how MDS care is evolving.

Nurses Vital Part of Team-Based Care for HSCT Patients with Hepatic VOD/SOD
Hepatic veno-occlusive/sinusoidal obstruction syndrome (VOD/SOD) is a serious complication of hematopoietic stem cell transplantation (HSCT) caused by toxicity that results in obstruction of small veins in the liver. It can occur in 10-20% of patients undergoing HSCT, and certain high-risk populations have even higher incidence. Mortality outcomes have improved over the past few years. However, as many as 30-60% of patients who develop hepatic VOD/SOD will experience severe morbidity including multiorgan dysfunction or failure. ...
Advertisement
Advertisement

Knowledge Hubs

GI Cancer
GI Cancer

Trending

Advertisement
Advertisement
Latest News